

Article in Japanese
A case of extensive-disease small cell lung cancer with Lambert-Eaton myasthenic syndrome successfully treated with platinum doublet and atezolizumab therapy
Juri Kawasakia Sakae Fujimotoa Hiroyuki Kamiyaa Takanori Miyoshib
aDepartment of Respiratory Medicine, Yuai Memorial Hospital
bDepartment of Respiratory Surgery, Yuai Memorial Hospital
A 67-year-old man was referred to our hospital with anorexia. As a result of detailed examination, he was diagnosed with small cell lung cancer. Additionally, gait impairment from lower limb muscle weakness, elevation of anti-P/Q-type voltage-gated calcium channel antibodies, and a waxing phenomenon during a 30-Hz stimulation on repetitive stimulation test led to a diagnosis of Lambert-Eaton myasthenic syndrome. Four cycles of platinum doublet and atezolizumab therapy resulted in a complete response. His muscle symptoms remained unchanged. Maintenance atezolizumab still continues today without tumor relapse or worsening of muscle symptoms.
Extensive-disease small cell lung cancer Anti-PD-L1 inhibitor Atezolizumab Lambert-Eaton myasthenic syndrome Anti-P/Q-type VGCC body
Received 10 Dec 2024 / Accepted 27 Jan 2025
AJRS, 14(3): 118-121, 2025